MD Newsline
In this episode of MD Newsline, Dr. Quentin Youmans, a heart failure cardiologist at Northwestern Medicine, explores the rapidly evolving landscape of advanced heart failure care. He shares insights into guideline-directed medical therapy, emerging device-based interventions, and the growing role of personalized medicine in improving outcomes for patients with complex cardiovascular disease. Dr. Youmans also addresses health disparities, access challenges, and the importance of multidisciplinary collaboration in modern cardiology. Episode Highlights Advances in Guideline-Directed Medical...
info_outlineMD Newsline
In this episode of MD Newsline, Dr. Aruna Anupindi, a consultant clinical oncologist based in Oxford, UK, joins the podcast to discuss evolving trends in breast and prostate cancer care. Specializing in breast and urological cancers, Dr. Anupindi shares insights from her clinical practice, highlights key takeaways from recent oncology conferences, and reflects on the growing importance of early detection, personalized therapies, and quality of life in cancer treatment. She also addresses disparities in screening uptake, emerging treatment strategies aimed at reducing chemotherapy exposure,...
info_outlineMD Newsline
In this episode of MD Newsline, Dr. Arsela Prelaj, a thoracic oncologist and AI researcher at the Istituto Nazionale dei Tumori in Milan, Italy, explores the rapidly evolving role of artificial intelligence in oncology. Drawing from her background in medical oncology and bioengineering, Dr. Prelaj discusses how AI is revolutionizing clinical trial design, improving trial success rates, and expanding patient access to innovative therapies. She shares real-world examples of how machine learning, large language models, and synthetic data are being integrated into cancer research, while also...
info_outlineMD Newsline
In this episode of MD Newsline, Dr. Sherene Loi, a medical oncologist and laboratory head at the Peter MacCallum Cancer Centre in Melbourne, Australia, discusses groundbreaking research published in Nature exploring how pregnancy and breastfeeding influence immune protection against triple-negative breast cancer. Dr. Loi shares insights into how reproductive history reshapes the immune system, particularly T cell activity, and how these findings may inform future prevention strategies, screening approaches, and immunotherapy development. Episode Highlights: The Immune System’s Role in...
info_outlineMD Newsline
In this episode of MD Newsline, Dr. Joel Wright, a rheumatology fellow at UCLA, provides an in-depth, practical discussion on axial spondyloarthritis and related spondyloarthritides. Dr. Wright breaks down evolving disease definitions, diagnostic challenges, imaging interpretation, and modern treatment strategies, while emphasizing a holistic, patient-centered approach to care. The conversation highlights how early recognition and individualized therapy can significantly improve long-term outcomes. Episode Highlights Defining Axial vs. Peripheral Spondyloarthritis Dr. Wright explains the...
info_outlineMD Newsline
In this episode of MD Newsline, Dr. Marianna Cortese, a medical doctor and epidemiologist at the Harvard T.H. Chan School of Public Health, shares groundbreaking research on the link between vitamin D, Epstein-Barr virus (EBV), and the risk of multiple sclerosis (MS). Her work, conducted within the U.S. military cohort, sheds new light on racial, genetic, and environmental factors influencing MS development and potential prevention strategies. Dr. Cortese discusses how vitamin D levels and immune response modulation play a role in MS prevention, and how EBV infection—now recognized as the...
info_outlineMD Newsline
In this episode of MD Newsline, patient advocate Tameka Carter shares her personal journey living with hidradenitis suppurativa (HS), a chronic, painful inflammatory skin condition often misdiagnosed for years. Tameka discusses the early signs of HS, the emotional and physical toll of delayed diagnosis, and the importance of finding a specialist who truly listens. She offers valuable insight into treatment decision-making, lifestyle changes, and the critical role of self-advocacy in managing a lifelong condition. Episode Highlights Early Symptoms and Delayed Diagnosis Tameka reflects on...
info_outlineMD Newsline
In this episode of MD Newsline, Dr. Gloria Dalla Costa, a researcher at Harvard University, shares groundbreaking insights into the role of ultra-processed foods in multiple sclerosis (MS) progression. Drawing from her research on environmental and metabolic risk factors, Dr. Dalla Costa discusses how dietary habits may influence inflammation, disease activity, and long-term neurological outcomes in MS patients. Her work reveals compelling evidence that higher consumption of ultra-processed foods correlates with increased inflammatory markers, worsened MRI outcomes, and a greater risk of...
info_outlineMD Newsline
In this episode of MD Newsline, Dr. Ahmed Abdelhak, Assistant Professor of Neurology at the University of California, San Francisco, explores the cutting-edge world of fluid biomarkers in multiple sclerosis (MS). With over a decade of experience as an MS clinical scientist, Dr. Abdelhak shares his expertise on the evolving role of biomarkers in understanding, predicting, and managing MS progression. He breaks down how markers like neurofilament light chain (NFL), glial fibrillary acidic protein (GFAP), and chitinase (CHIT1/CHIT3) offer insights into the underlying neuroinflammatory and...
info_outlineMD Newsline
In this episode of MD Newsline, Dr. Nilüfer Kale, Head of the Department of Neurology at Başakşehir Çam and Sakura City Hospital in Istanbul, Turkey, provides an in-depth look into optic neuritis, multiple sclerosis (MS), and related demyelinating disorders. She discusses the pathophysiology, diagnostic challenges, and treatment evolution of these conditions—offering valuable insights for clinicians managing autoimmune neuroinflammatory diseases. Dr. Kale also highlights the importance of accurate differential diagnosis, the role of neuroimaging and biomarkers, and how advancements in...
info_outlineIn this episode of MD Newsline, Dr. Rachael Sood, a diabetes nurse practitioner and certified diabetes care and education specialist from New Orleans, Louisiana, shares her insights from the 85th American Diabetes Association Scientific Sessions. As the founder of The Diabetes Collective, Dr. Sood discusses the evolution of diabetology—a specialized field focused solely on the identification, treatment, and management of diabetes across all patient populations.
Dr. Sood explores how personalized diagnostics, innovative technology, and education-driven care models are reshaping outcomes for patients with type 1, type 2, and prediabetes. She highlights the importance of accurate diagnosis, the role of genetic predisposition, and why clinicians must move beyond relying solely on hemoglobin A1C levels to ensure proper disease identification and management.
Episode HighlightsTransforming the Diagnosis and Management of Diabetes Dr. Sood explains the principles of diabetology and how it differs from traditional endocrinology. She emphasizes comprehensive assessment, including antibody screening, glucose monitoring, and the integration of genomic insights to accurately distinguish between type 1 and type 2 diabetes.
Technology as a Game-Changer in Diabetes Care Dr. Sood shares how continuous glucose monitors (CGMs) and insulin pumps have revolutionized real-time patient engagement. These smart biosensors empower patients to understand how lifestyle, stress, and nutrition directly affect glucose levels, fostering self-awareness and adherence to treatment plans.
Overcoming Clinical Inertia and Patient Barriers She highlights the need to address clinical inertia, encouraging clinicians to adapt treatment plans as patients' needs evolve. Dr. Sood underscores the importance of patient education, empathy, and collaboration with family and community networks to improve adherence and reduce care fatigue.
Breakthroughs in Treatment and Research Reporting from the ADA conference, Dr. Sood discusses the promising results of Vertex Pharmaceuticals' islet cell therapy, which shows evidence of restoring natural insulin production in type 1 diabetes. She also explains the role of TZLD (teplizumab) in delaying the onset of type 1 diabetes, potentially changing the disease trajectory for high-risk patients.
Next-Generation Therapies and GLP-1 Innovation Dr. Sood breaks down the expanding role of GLP-1 receptor agonists—from glucose regulation to benefits in cardiovascular health, weight management, and chronic kidney disease. She reveals data on the new CagreSema combination therapy, which combines semaglutide with an amylin analog, showing over 20% weight reduction and improved metabolic outcomes.
Insurance and Access Challenges Dr. Sood addresses the ongoing struggle of insurance coverage, prior authorizations, and high costs for new medications, offering practical advice for clinicians and patients to navigate access through manufacturer programs and cash-based options.
Key Takeaway Dr. Sood emphasizes that diabetes care is entering a transformative era—one defined by early detection, patient empowerment, and precision medicine. With new therapies, technologies, and care models emerging rapidly, collaboration among clinicians, patients, and innovators will be essential to achieving long-term success in diabetes prevention and management.
ResourcesWebsite: https://mdnewsline.com/ Newsletter: https://mdnewsline.com/subscribe/
Connect with Dr. Rachael Sood: Here
Hosted on Acast. See acast.com/privacy for more information.